文献速递外周动脉疾病

分期闭合的斩断式经跖骨截肢促进晚期慢性肢体威胁性缺血患者的早期行走与保肢

Guillotine Transmetatarsal Amputations With Staged Closure Promote Early Ambulation and Limb Salvage in Patients With Advanced Chronic Limb-Threatening Ischemia.
PubMed 文献 · J Endovasc Ther · 2022-12-24

单中心回顾性队列研究纳入2017至2020年接受斩断式经跖骨截肢(gTMA)的44例晚期慢性肢体威胁性缺血(CLTI)患者,中位随访381天。87.8%患者术后中位2天恢复行走,1年保肢率84.1%、伤口愈合率54.5%、生存率88.6%;应用全厚皮片移植与伤口愈合显著相关(p=0.002,OR=16.5,95%CI 2.87-94.81)。作者认为gTMA可获得高保肢率,辅助全厚皮片移植可能促进伤口愈合。

要点

  • 87.8%(n=36)患者gTMA术后中位2天(IQR 1-3)恢复行走。
  • 1年保肢率84.1%、伤口愈合率54.5%、生存率88.6%。
  • 全厚皮片移植与伤口愈合显著相关(p=0.002,OR=16.5,95%CI 2.87-94.81)。

核心结论

  • gTMA在长期随访中为CLTI患者带来高保肢率。
  • 辅助全厚皮片移植可能促进gTMA部位伤口愈合,从而加快伤口闭合。
  • 作者认为,外科医生可考虑将gTMA作为高危大截肢CLTI患者减少肢体丢失的替代方案。

研究设计与样本

  • 单中心回顾性队列研究,纳入2017至2020年接受gTMA的CLTI患者44例。
  • 采用Kaplan-Meier分析量化保肢率、伤口愈合率和生存率。
  • 采用多因素回归分析患者特征对结局的影响。

主要发现

  • 中位随访381天(IQR 212-539.75天)。
  • 87.8%(n=36)患者gTMA术后中位2天(IQR 1-3)恢复行走。
  • 最终覆盖采用个体化分期方案,联合皮肤替代物(88.6%,n=39)±全厚皮片移植(61.4%,n=27)。
  • Kaplan-Meier估计1年保肢率84.1%、伤口愈合率54.5%、生存率88.6%;2年分别为81.8%、63.8%、84.1%。
  • 伤口愈合与全厚皮片移植应用显著相关(p=0.002,OR=16.5,95%CI 2.87-94.81)。

临床怎么用

  • 作者认为,gTMA可作为高危大截肢CLTI患者减少肢体丢失的替代方案供外科医生考虑。
  • 作者认为,在积极的多学科团队背景下,gTMA可通过合理使用真皮替代物和皮片移植实现愈合,从而保留肢体、维持活动能力、避免肌少症并减轻衰弱。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Transmetatarsal amputation (TMA) with primary closure has long been an option for limb salvage in patients with advanced chronic limb-threatening ischemia (CLTI) with extensive tissue loss of the forefoot. However, TMA healing and closure techniques are challenging, specifically in high-risk patients. Guillotine transmetatarsal amputations (gTMA) with staged closure may provide an alternative treatment in this population. We report long-term outcomes of such technique. MATERIALS AND METHODS: A single-center retrospective cohort study of CLTI patients undergoing gTMA between 2017 and 2020 was performed. Limb salvage, wound healing, and survival rates were quantified using Kaplan-Meier (KM) analysis. Multivariate regression was used to identify the effect of patient characteristics on the outcomes. RESULTS: Forty-four gTMA procedures were reviewed. Median follow-up was 381 (interquartile range [IQR], 212-539.75) days. After gTMA, 87.8% (n=36) of the patients were able to ambulate after a median interval of 2 (IQR, 1-3) days. Eventual coverage was achieved in a personalized and staged approach by using a combination of skin substitutes (88.6%, n=39) ± split thickness skin grafts (STSG, 61.4%, n=27). KM estimates for limb salvage, wound healing, and survival were 84.1%, 54.5%, and 88.6% at 1 year and 81.8%, 63.8%, and 84.1% at 2 years. Wound healing was significantly associated with STSG application (p=0.002, OR=16.5, 95% CI 2.87-94.81). CONCLUSION: gTMA resulted in high limb salvage rates during long-term follow-up in CLTI patients. Adjunctive STSG placement may enhance wound healing at the gTMA site, thus leading to expedited wound closure. Surgeons may consider gTMA as an alternative to reduce limb loss in CLTI patients at high risk of major amputation. CLINICAL IMPACT: Currently, the clinical presentation of CLTI is becoming more complex to deal with due to the increasing comorbidities as the society becomes older. The data shown in this article means for clinicians that when facing diffused forefoot gangrene and extensive tissue loss, limb preservation could still be considered instead of major amputation. Guillotine transmetatarsal amputations in the setting of an aggressive multidisciplinary group, can be healed by the responsibly utilization of dermal substitutes and skin grafts leading to the preservation of the extremity, allowing mobility, avoiding of sarcopenia, and decreasing frailty. This will equate to maintenance of independent living and preservation of lifespan.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Lepow BD, Zulbaran-Rojas A, Park C, et al. Guillotine Transmetatarsal Amputations With Staged Closure Promote Early Ambulation and Limb Salvage in Patients With Advanced Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2022. PMID: 36565249. doi:10.1177/15266028221144587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。